10-Q 1 iknx-20170630x10q.htm 10-Q iknx_Current_Folio_10Q_for_Q2_Q3

 

 

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

(Mark One)

 

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the Quarterly Period Ended June 30, 2017

 

or

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the Transition Period From                                to                                 .

 

Commission file number 000-25727

 

IKONICS CORPORATION

(Exact name of registrant as specified in its charter)

Minnesota

 

41-0730027

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. employer

identification no.)

 

 

 

4832 Grand Avenue

Duluth, Minnesota

 

55807

(Address of principal executive offices)

 

(Zip code)

(218) 628-2217

Registrant’s telephone number

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.)  Yes ☒  No ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐  No ☒

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐

 

Accelerated filer ☐

Non-accelerated filer (Do not check if a smaller reporting company) ☐

 

Smaller reporting company ☒

 

 

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: Common Stock, $.10 par value per share - 2,017,053 shares outstanding as of August 4, 2017.

 

 

 

 

 


 

IKONICS Corporation

 

QUARTERLY REPORT ON FORM 10-Q

 

 

 

PAGE NO.

PART I. 

FINANCIAL INFORMATION

 

 

 

 

Item 1. 

 

Condensed Financial Statements:

 

 

 

 

 

 

 

Condensed Balance Sheets as of June 30, 2017 (unaudited) and December 31, 2016

1

 

 

 

 

 

 

Condensed Statements of Operations for the Three Months and Six Months Ended June 30, 2017 and 2016 (unaudited)

2

 

 

 

 

 

 

Condensed Statements of Cash Flows for the Six Months Ended June 30, 2017 and 2016 (unaudited)

3

 

 

 

 

 

 

Notes to Condensed Financial Statements (unaudited)

4

 

 

 

 

Item 2. 

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

10

 

 

 

 

Item 3. 

 

Quantitative and Qualitative Disclosures about Market Risk

16

 

 

 

 

Item 4. 

 

Controls and Procedures

16

 

 

 

PART II. 

OTHER INFORMATION

17

 

 

 

 

SIGNATURES

 

 

 

 

 

2


 

PART I - FINANCIAL INFORMATION

 

ITEM 1.  Condensed Financial Statements

 

IKONICS CORPORATION

CONDENSED BALANCE SHEETS

 

 

 

 

 

 

 

 

 

 

June 30,

 

December 31,

 

 

    

2017

    

2016

 

 

 

 

(unaudited)

 

 

 

 

ASSETS

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

1,240,086

 

$

1,048,713

 

Short-term investments

 

 

2,895,000

 

 

3,246,000

 

Trade receivables, less allowance of $52,000 in 2017 and $54,000 in 2016

 

 

2,066,736

 

 

2,336,501

 

Inventories

 

 

2,276,601

 

 

1,986,172

 

Prepaid expenses and other assets

 

 

146,772

 

 

361,905

 

Income taxes receivable

 

 

273,973

 

 

66,181

 

Total current assets

 

 

8,899,168

 

 

9,045,472

 

PROPERTY, PLANT, AND EQUIPMENT, at cost:

 

 

 

 

 

 

 

Land and building

 

 

9,201,846

 

 

9,189,743

 

Machinery and equipment

 

 

4,950,091

 

 

4,884,814

 

Office equipment

 

 

1,600,760

 

 

1,566,856

 

Vehicles

 

 

269,941

 

 

272,144

 

 

 

 

16,022,638

 

 

15,913,557

 

Less accumulated depreciation

 

 

(7,397,569)

 

 

(7,001,162)

 

 

 

 

8,625,069

 

 

8,912,395

 

INTANGIBLE ASSETS, less accumulated amortization of $162,032 in 2017 and $149,072 in 2016

 

 

340,211

 

 

338,127

 

 

 

$

17,864,448

 

$

18,295,994

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

Current portion of long-term debt, net

 

$

129,086

 

$

127,303

 

Accounts payable

 

 

874,795

 

 

730,386

 

Accrued compensation

 

 

337,394

 

 

388,600

 

Other accrued liabilities

 

 

91,398

 

 

67,088

 

Total current liabilities

 

 

1,432,673

 

 

1,313,377

 

LONG-TERM LIABILITIES

 

 

 

 

 

 

 

Long-term debt, less current portion, net

 

 

3,012,299

 

 

3,077,457

 

Deferred income taxes

 

 

446,000

 

 

446,000

 

Total long-term liabilities

 

 

3,458,299

 

 

3,523,457

 

Total liabilities

 

 

4,890,972

 

 

4,836,834

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

Preferred stock, par value $.10 per share; authorized 250,000 shares; none issued

 

 

 —

 

 

 —

 

Common stock, par value $.10 per share; authorized 4,750,000 shares; issued and outstanding 2,017,053 shares in 2017 and 2,018,753 shares in  2016

 

 

201,705

 

 

201,875

 

Additional paid-in-capital

 

 

2,742,659

 

 

2,732,006

 

Retained earnings

 

 

10,029,112

 

 

10,525,279

 

Total stockholders’ equity

 

 

12,973,476

 

 

13,459,160

 

 

 

$

17,864,448

 

$

18,295,994

 

 

See notes to condensed financial statements.

 

1


 

IKONICS CORPORATION

CONDENSED STATEMENTS OF OPERATIONS (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Three Months Ended

 

Six Months Ended

 

 

    

June 30,

 

June 30,

 

 

    

2017

    

2016

    

2017

    

2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET SALES

 

$

4,685,361

 

$

4,196,578

 

$

8,314,353

 

$

8,209,788

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COST OF GOODS SOLD

 

 

3,242,097

 

 

2,674,367

 

 

5,780,861

 

 

5,390,903

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GROSS PROFIT

 

 

1,443,264

 

 

1,522,211

 

 

2,533,492

 

 

2,818,885

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

 

 

1,393,636

 

 

1,325,170

 

 

2,904,250

 

 

2,764,286

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RESEARCH AND DEVELOPMENT EXPENSES

 

 

184,704

 

 

147,125

 

 

350,474

 

 

324,989

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME (LOSS) FROM OPERATIONS

 

 

(135,076)

 

 

49,916

 

 

(721,232)

 

 

(270,390)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INTEREST EXPENSE

 

 

(20,826)

 

 

(14,999)

 

 

(41,643)

 

 

(14,999)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OTHER

 

 

5,902

 

 

2,048

 

 

11,055

 

 

2,162

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME (LOSS) BEFORE INCOME TAXES

 

 

(150,000)

 

 

36,965

 

 

(751,820)

 

 

(283,227)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME TAX BENEFIT

 

 

(44,934)

 

 

(2,260)

 

 

(267,857)

 

 

(129,640)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET INCOME (LOSS)

 

$

(105,066)

 

$

39,225

 

$

(483,963)

 

$

(153,587)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME (LOSS) PER COMMON SHARE:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.05)

 

$

0.02

 

$

(0.24)

 

$

(0.08)

 

Diluted

 

$

(0.05)

 

$

0.02

 

$

(0.24)

 

$

(0.08)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

2,018,466

 

 

2,018,753

 

 

2,018,609

 

 

2,018,544

 

Diluted

 

 

2,018,466

 

 

2,018,833

 

 

2,018,609

 

 

2,018,544

 

 

See notes to condensed financial statements.

2


 

IKONICS CORPORATION

CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)

 

 

 

 

 

 

 

 

 

 

    

Six Months Ended

 

 

 

June 30,

 

 

 

2017

    

2016

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

Net loss

 

$

(483,963)

 

$

(153,587)

 

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation

 

 

421,412

 

 

352,000

 

Amortization

 

 

19,149

 

 

14,385

 

Stock based compensation

 

 

11,494

 

 

11,763

 

      Net gain on sale and disposal of property, plant and equipment

 

 

(21,707)

 

 

(5,750)

 

Changes in working capital components:

 

 

 

 

 

 

 

Trade receivables

 

 

269,765

 

 

353,963

 

Inventories

 

 

(290,429)

 

 

(95,743)

 

Prepaid expenses and other assets

 

 

215,133

 

 

(55,625)

 

Income tax receivable

 

 

(207,854)

 

 

(28,882)

 

Accounts payable

 

 

144,409

 

 

90,470

 

Accrued expenses

 

 

(26,896)

 

 

45,214

 

Net cash provided by operating activities

 

 

50,513

 

 

528,208

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

Purchases of property, plant, equipment and construction in progress

 

 

(134,086)

 

 

(1,843,879)

 

Proceeds from sale of property, plant and equipment

 

 

21,707

 

 

21,000

 

Purchases of intangibles

 

 

(15,044)

 

 

(22,395)

 

Purchases of short-term investments

 

 

(1,915,000)

 

 

(3,399,000)

 

Proceeds on sale of short-term investments

 

 

2,266,000

 

 

 —

 

Net cash provided by (used in) investing activities

 

 

223,577

 

 

(5,244,274)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

Proceeds from long-term debt

 

 

 —

 

 

3,415,000

 

Payment of debt issuance costs

 

 

 —

 

 

(139,418)

 

Payments on long-term debt

 

 

(69,564)

 

 

(10,858)

 

Repurchase of common stock

 

 

(15,038)

 

 

 —

 

Proceeds from exercise of stock options

 

 

1,885

 

 

3,765

 

Net cash provided by (used in) financing activities

 

 

(82,717)

 

 

3,268,489

 

 

 

 

 

 

 

 

 

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

 

 

191,373

 

 

(1,447,577)

 

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

 

 

1,048,713

 

 

2,248,466

 

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS AT END OF PERIOD

 

$

1,240,086

 

$

800,889

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

 

 

 

 

 

 

 

Construction in progress included in accounts payable

 

$

 —

 

$

60,166

 

Cash paid for interest

 

$

35,776

 

$

6,699

 

    Cash received for income taxes, net

 

$

60,003

 

$

100,758

 

 

See notes to condensed financial statements.

 

 

3


 

Table of Contents

IKONICS CORPORATION

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

 

(Unaudited)

 

1.Basis of Presentation

 

The condensed balance sheet of IKONICS Corporation (the “Company”) as of June 30, 2017, and the related condensed statements of operations for the three and six months ended June 30, 2017 and 2016, and cash flows for the six months ended June 30, 2017 and 2016, have been prepared without being audited.

 

In the opinion of management, these statements reflect all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the financial position of IKONICS Corporation as of June 30, 2017, and the results of operations and cash flows for all periods presented.

 

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America, have been condensed or omitted.  Therefore, these statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.

 

The results of operations for interim periods are not necessarily indicative of results that will be realized for the full fiscal year.

 

2.Short-Term Investments

 

The Company’s $2.9 million of short-term investments at June 30, 2017 is comprised of twelve fully insured certificates of deposit with original maturities ranging from six to twelve months and interest rates ranging from 0.65% to 1.25%.

 

3.Inventories

 

The major components of inventories are as follows:

 

 

 

 

 

 

 

 

 

 

    

Jun 30, 2017

    

Dec 31, 2016

 

 

 

 

 

 

 

 

 

Raw materials

 

$

1,634,801

 

$

1,438,471

 

Work-in-progress

 

 

381,212

 

 

355,208

 

Finished goods

 

 

1,396,987

 

 

1,319,856

 

Reduction to LIFO cost

 

 

(1,136,399)

 

 

(1,127,363)

 

 

 

 

 

 

 

 

 

Total Inventories

 

$

2,276,601

 

$

1,986,172

 

 

 

4.Earnings Per Common Share (EPS)

 

Basic EPS is calculated using net income (loss) divided by the weighted average of common shares outstanding.  Diluted EPS is similar to Basic EPS except that the weighted average number of common shares outstanding is increased to include the number of additional common shares that would have been outstanding if the potential dilutive common shares, such as those shares subject to options, had been issued.

 

4


 

Table of Contents

IKONICS CORPORATION

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

 

(Unaudited)

 

Shares used in the calculation of diluted EPS are summarized below:

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

    

Jun 30, 2017

    

Jun 30, 2016

  

 

 

 

 

 

 

Weighted average common shares outstanding

 

2,018,466

 

2,018,753

 

Dilutive effect of stock options

 

 —

 

80

 

Weighted average common and common equivalent shares outstanding

 

2,018,466

 

2,018,833

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

    

Jun 30, 2017

    

Jun 30, 2016

  

 

 

 

 

 

 

Weighted average common shares outstanding

 

2,018,609

 

2,018,544

 

Dilutive effect of stock options

 

 —

 

 —

 

Weighted average common and common equivalent shares outstanding

 

2,018,609

 

2,018,544

 

 

Options to purchase 11,418 shares of common stock with a weighted average price of $15.99 were outstanding during the three months ended June 30, 2016, but were excluded from the computation of common share equivalents because they were anti-dilutive.  If the Company was in a net income position for the three months ended June 30, 2017, all 18,168 options outstanding with a weighted average exercise price of $13.81 would have remained excluded from the computation of common share equivalents as the options were anti-dilutive.

 

If the Company was in a net income position for the first six months of 2017, 2,250 options outstanding with a weighted average exercise price of $8.91 would have been included as part of the weighted average common and common equivalent shares outstanding as the options would have been dilutive while 15,918 options outstanding with a weighted average exercise price of $14.51 would have remained excluded as the options were anti-dilutive.  

 

If the Company was in a net income position for the first six months of 2016, 4,750 options outstanding with a weighted average exercise price of $10.59 would have been included as part of the weighted average common and common equivalent shares outstanding as the options would have been dilutive while 11,418 options outstanding with a weighted average exercise price of $15.99 would have remained excluded as the options were anti-dilutive.  

 

 

5.Stock-Based Compensation

 

The Company maintains a stock incentive plan which authorizes the issuance of up to 442,750 shares of common stock. Of those shares, 18,168 were subject to outstanding options and 101,989 were reserved for future grants at June 30, 2017. The plan provides for granting eligible participants stock options or other stock awards, as described by the plan, at option prices ranging from 85% to 110% of fair market value at the date of grant.  Options granted expire up to seven years after the date of grant.  Such options generally become exercisable over a one- to three-year period.

 

5


 

Table of Contents

IKONICS CORPORATION

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

 

(Unaudited)

 

The Company charged compensation cost of approximately $6,000 against income for the three months ended June 30, 2017 and approximately $6,500 for the three months ended June 30, 2016. For the first six months of 2017, the Company charged compensation cost of approximately $11,500 and approximately $11,800 for the same period in 2016.  As of June 30, 2017, there was approximately $29,100 of unrecognized compensation cost related to unvested share-based compensation awards. That cost is expected to be recognized over the next three years.

 

The Company receives a tax deduction for certain stock option exercises during the period in which the options are exercised, generally for the excess of the market price at the time the stock options are exercised over the exercise price of the options.

 

Proceeds from the exercise of 250 stock options were approximately $2,000 for the six months ended June 30, 2017 while proceeds from the exercise of 500 stock options were approximately $4,000 for the six months ended June 30, 2016.

 

The fair value of options granted during the six months ended June 30, 2017 and 2016 was estimated using the Black-Scholes option pricing model with the following assumptions:

 

 

 

 

 

 

 

 

    

2017

    

2016

 

Dividend yield

 

0%

 

0%

 

Expected volatility

 

41.3%

 

42.4%

 

Expected life of option

 

Five Years

 

Five Years

 

Risk-free interest rate

 

1.8%

 

1.3%

 

Fair value of each option on grant date

 

$ 3.43

 

$ 4.02

 

 

There were 2,250 and 4,500 options granted during each of the six months ended June 30, 2017 and 2016, respectively. 

 

Stock option activity during the six months ended June 30, 2017 was as follows:

 

 

 

 

 

 

 

 

 

    

 

    

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Exercise

 

 

    

Shares

    

Price

 

Outstanding at January 1, 2017

 

16,168

 

$

14.40

 

Granted

 

2,250

 

 

8.91

 

Exercised

 

(250)

 

 

7.54

 

Outstanding at June 30, 2017

 

18,168

 

$

13.81

 

Exercisable at June 30, 2017

 

10,499

 

$

15.41

 

 

The aggregate intrinsic value of all options outstanding and for those exercisable at June 30, 2017 was approximately $1,000 and $0, respectively.

 

 

 

 

 

 

6


 

Table of Contents

IKONICS CORPORATION

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

 

(Unaudited)

 

6.Segment Information

 

The Company’s reportable segments are strategic business units that offer different products and have varied customer bases.  There are five reportable segments:  Domestic, Export, IKONICS Imaging, Digital Texturing (DTX) and Advanced Material Solutions (AMS).  Domestic sells screen printing film, emulsions, and inkjet receptive film to distributors located in the United States and Canada.  IKONICS Imaging sells photo resistant film, art supplies, glass, metal medium and related abrasive etching equipment to end user customers located in the United States and Canada.  AMS provides sound deadening and weight reduction technology to the aerospace industry along with products and services for etched composites, ceramics, glass and silicon wafers.  DTX includes products and customers related to patented and proprietary inkjet technology used for mold texturing and prototyping. Export sells primarily the same products as Domestic and the IKONICS Imaging products not related to AMS or DTX. The accounting policies applied to determine the segment information are the same as those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.

 

Management evaluates the performance of each segment based on the components of divisional income.  Assets and liabilities are not allocated to segments, except for trade receivables which are allocated based on the previous segmentation.  Financial information with respect to the reportable segments follows:

 

For the three months ended June 30, 2017:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IKONICS

 

 

 

 

 

 

 

 

 

 

IKONICS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Domestic

 

Export

 

Imaging

 

DTX

 

AMS

 

Unalloc.

 

Total

 

Net sales

 

$

1,816,956

 

$

1,372,092

 

$

943,055

 

$

471,244

 

$

82,014

 

$

 

$

4,685,361

 

Cost of goods sold

 

 

1,034,059

 

 

1,096,279

 

 

453,213

 

 

358,937

 

 

299,609

 

 

 

 

3,242,097

 

Gross profit (loss)

 

 

782,897

 

 

275,813

 

 

489,842

 

 

112,307

 

 

(217,595)

 

 

 

 

1,443,264

 

Selling, general and administrative*

 

 

334,071

 

 

189,741

 

 

253,746

 

 

50,861

 

 

104,325

 

 

460,892

 

 

1,393,636

 

Research and development*

 

 

 

 

 

 

 

 

 

 

 

 

184,704

 

 

184,704

 

Income (loss) from operations

 

$

448,826

 

$

86,072

 

$

236,096

 

$

61,446

 

$

(321,920)

 

$

(645,596)

 

$

(135,076)

 

 

For the three months ended June 30, 2016:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IKONICS

 

 

 

 

 

 

 

 

 

 

IKONICS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Domestic

 

Export

 

Imaging

 

DTX

 

AMS

 

Unalloc.

 

Total

 

Net sales

 

$

1,943,516

 

$

953,585

 

$

999,596

 

$

33,476

 

$

266,405

 

$

 —

 

$

4,196,578

 

Cost of goods sold

 

 

1,105,206

 

 

735,169

 

 

425,120

 

 

35,062

 

 

373,810

 

 

 —

 

 

2,674,367

 

Gross profit (loss)

 

 

838,310

 

 

218,416

 

 

574,476

 

 

(1,586)

 

 

(107,405)

 

 

 

 

1,522,211

 

Selling, general and administrative*

 

 

345,000

 

 

159,621

 

 

247,682

 

 

39,630

 

 

123,286

 

 

409,951

 

 

1,325,170

 

Research and development*

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

147,125

 

 

147,125

 

Income (loss) from operations

 

$

493,310

 

$

58,795

 

$

326,794

 

$

(41,216)

 

$

(230,691)

 

$

(557,076)

 

$

49,916

 

 

7


 

Table of Contents

IKONICS CORPORATION

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

 

(Unaudited)

 

For the six months ended June 30, 2017:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IKONICS

 

 

 

 

 

 

 

 

 

 

IKONICS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Domestic

 

Export

 

Imaging

 

DTX

 

AMS

 

Unalloc.

 

Total

 

Net sales

 

$

3,120,525

 

$

2,427,097

 

$

1,933,041

 

$

586,475

 

$

247,215

 

$

 

$

8,314,353

 

Cost of goods sold

 

 

1,860,800

 

 

1,935,643

 

 

976,793

 

 

394,419

 

 

613,206

 

 

 

 

5,780,861

 

Gross profit (loss)

 

 

1,259,725

 

 

491,454

 

 

956,248

 

 

192,056

 

 

(365,991)

 

 

 

 

2,533,492

 

Selling, general and administrative*

 

 

685,493

 

 

385,858

 

 

537,605

 

 

85,496

 

 

201,120

 

 

1,008,678

 

 

2,904,250

 

Research and development*

 

 

 

 

 

 

 

 

 

 

 

 

350,474

 

 

350,474

 

Income (loss) from operations

 

$

574,232

 

$

105,596

 

$

418,643

 

$

106,560

 

$

(567,111)

 

$

(1,359,152)

 

$

(721,232)

 

 

For the six months ended June 30, 2016:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IKONICS

 

 

 

 

 

 

 

 

 

 

IKONICS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Domestic

    

Export

    

Imaging

    

DTX

    

AMS

    

Unalloc.

    

Total

 

Net sales

 

$

3,297,244

 

$

2,196,770

 

$

2,117,294

 

$

110,356

 

$

488,124

 

$

 —

 

$

8,209,788

 

Cost of goods sold

 

 

1,951,605

 

 

1,697,658

 

 

964,902

 

 

70,486

 

 

706,252

 

 

 —

 

 

5,390,903

 

Gross profit (loss)

 

 

1,345,639

 

 

499,112

 

 

1,152,392

 

 

39,870

 

 

(218,128)

 

 

 

 

2,818,885

 

Selling, general and administrative*

 

 

704,397

 

 

302,652

 

 

499,053

 

 

74,373

 

 

227,189

 

 

956,622

 

 

2,764,286

 

Research and development*

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

324,989

 

 

324,989

 

Income (loss) from operations

 

$

641,242

 

$

196,460

 

$

653,339

 

$

(34,503)

 

$

(445,317)

 

$

(1,281,611)

 

$

(270,390)

 

 


*The Company does not allocate all general and administrative expenses or any research and development expenses to its operating segments for internal reporting.

 

Trade receivables by segment as of June 30, 2017 and December 31, 2016 were as follows:

 

 

 

 

 

 

 

 

 

 

    

Jun 30, 2017

    

Dec 31, 2016

 

 

 

 

 

 

 

 

 

Domestic

 

$

863,407

 

$

1,206,866

 

Export

 

 

773,376

 

 

551,803

 

IKONICS Imaging

 

 

268,345

 

 

363,602

 

DTX

 

 

142,013

 

 

52,935

 

AMS

 

 

36,366

 

 

177,374

 

Unallocated

 

 

(16,771)

 

 

(16,079)

 

 

 

 

 

 

 

 

 

Total

 

$

2,066,736

 

$

2,336,501

 

 

 

7.Income Taxes

 

The Company reports a liability for unrecognized tax benefits taken or expected to be taken when they are uncertain.  As of June 30, 2017 and June 30, 2016, there was no liability for unrecognized tax benefits.

 

The Company is subject to taxation in the United States and various states.  The material jurisdictions that are subject to examination by tax authorities primarily include Minnesota and the United States, in each case for tax years 2014, 2015, and 2016.

 

8


 

Table of Contents

IKONICS CORPORATION

 

NOTES TO CONDENSED FINANCIAL STATEMENTS

 

(Unaudited)

 

8.Subsequent Event

On August 3, 2017, the Company’s board of directors approved a new repurchase authorization for 100,000 shares of the Company’s common stock, which replaces all prior authorizations.  The new share repurchase authorization does not have an expiration date.

 

 

9


 

IKONICS CORPORATION

 

The information presented below in Management’s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements within the meaning of the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended.  Statements that are not historical or current facts, including statements about beliefs and expectations, are forward-looking statements. These forward-looking statements include statements relating to our future plans and objectives and results. Such statements are subject to risks and uncertainties, including those discussed elsewhere in this report and under the heading “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2016, as updated in our subsequent reports filed with the SEC, which could cause actual results to differ materially from those projected.  Because actual results may differ, readers are cautioned not to place undue reliance on these forward-looking statements.

 

ITEM 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following management’s discussion and analysis focuses on those factors that had a material effect on the Company’s financial results of operations during the second quarter of 2017 and first six months of 2017, as well as the same periods of 2016.  It should be read in connection with the Company’s condensed unaudited financial statements and notes thereto included in this Form 10-Q.

 

Critical Accounting Estimates

 

The Company prepares its financial statements in conformity with accounting principles generally accepted in the United States of America.  Therefore, the Company is required to make certain estimates, judgments and assumptions that the Company believes are reasonable based upon the information available.  These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented.  The accounting estimates, which IKONICS believes are the most critical to aid in fully understanding and evaluating its reported financial results, include the following:

 

Trade Receivables.  The Company performs ongoing credit evaluations of its customers and adjusts credit limits based upon payment history and the customer’s current credit worthiness, as determined by review of the current credit information.  The Company continuously monitors collections and payments from its customers and maintains a provision for estimated credit losses based upon historical experience and any specific customer collection issues that have been identified.  While such credit losses have historically been within expectations and the provisions established, the Company cannot guarantee that it will continue to experience the same collection history that has occurred in the past.  The general payment terms are net 30-45 days for domestic customers and net 30-90 days for foreign customers.  A small percentage of the trade receivables balance is denominated in a foreign currency with no concentration in any given country.  At the end of each reporting period, the Company analyzes the receivable balance for customers paying in a foreign currency.  These balances are adjusted to each quarter or year-end spot rate in accordance with the Financial Accounting Standards Board (“FASB”) ASC 830, Foreign Currency Matters.  The Company also maintains a provision for any customer related returns based upon historical experience of actual returns and any specifically identified product issues, refunds or credits.

 

Inventories.  Inventories are valued at the lower of cost or market value using the last in, first out (LIFO) method.  The Company monitors its inventory for obsolescence and records reductions from cost when required.

 

Income Taxes.  Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences.  Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.  The Company follows the accounting standard on accounting for uncertainty in income taxes, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.  Under this guidance, the Company may recognize the tax

10


 

benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement.  The guidance on accounting for uncertainty in income taxes also addresses derecognition, classification, interest and penalties on income taxes, and accounting in interim periods.

 

Revenue Recognition.  The Company recognizes revenue on sales of products when title passes, which can occur at the time of shipment or when the goods arrive at the customer location depending on the agreement with the customer.  The Company sells its products to both distributors and end-users.  Sales to distributors and end-users are recorded based upon the criteria governed by the sales, delivery, and payment terms stated on the invoices from the Company to the purchaser.  In addition to transfer of title / risk of loss, all revenue is recorded in accordance with the criteria outlined within Staff Accounting Bulletin No. 104 and FASB ASC 605, Revenue Recognition:

 

(a)

persuasive evidence of an arrangement (principally in the form of customer sales orders and the Company’s sales invoices);

 

(b)

delivery and performance (evidenced by proof of delivery, e.g. the shipment of film and substrates with bill of lading used for proof of delivery for FOB shipping point terms, and the carrier booking confirmation report used for FOB destination terms).  Once the finished product is shipped and physically delivered under the terms of the invoice and sales order, the Company has no additional performance or service obligations to complete;

 

(c)

a fixed and determinable sales price (the Company’s pricing is established and is not based on variable terms, as evidenced in either the Company’s invoices or the limited number of distribution agreements; the Company rarely grants extended payment terms and has no history of concessions); and

 

(d)

a reasonable likelihood of payment (the Company’s terms are standard, and the Company does not have a substantial history of customer defaults or non-payment).

 

Sales are reported on a net basis by deducting credits, estimated normal returns and discounts.  The Company’s return policy does not vary by geography.  The customer has no rotation or price protection rights and the Company is not under a warranty obligation.  Freight billed to customers is included in sales.  Shipping costs are included in cost of goods sold.

 

Results of Operations

 

Quarter Ended June 30, 2017 Compared to Quarter Ended June 30, 2016

 

Sales.    The Company realized an 11.6% sales increase during the second quarter of 2017 with sales of $4.7 million, compared to $4.2 million in sales during the same period in 2016.  Second quarter sales were favorably impacted by a DTX sales increase due to the sale of two printers and improved consumable sales.  DTX sales for the second quarter of 2017 increased from $33,000 in 2016 to $471,000, a $438,000 increase.  Export sales also realized a 43.9% sales increase in the second quarter as sales grew from $954,000 in 2016 to $1.4 million in 2017 due mainly to increased sales to Asia and Latin America. Part of the second quarter sales increase was related to the timing of sales between the first and second quarter of 2017.  Partially offsetting these sale increases was a $127,000, or 6.5%, decrease in Domestic sales for the second quarter of 2017 versus the same period in 2016 mainly related to softer artwork film sales.  AMS also posted lower sales in the second quarter of 2017 as sales decreased from $266,000 in the second quarter of 2016 to $82,000.  The AMS sales decrease was related to an anticipated temporary decrease in orders from AMS’s largest customer.  It is expected that this customer will return to its normal ordering pattern in the third quarter of 2017.  IKONICS Imaging sales decreased from $1.0 million in the second quarter of 2016 to $943,000 in the second quarter of 2017, a $57,000, or 5.7% decrease.   

 

11


 

Gross Profit.  Gross profit was $1.4 million, or 30.8% of sales, in the second quarter of 2017 compared to $1.5 million, or 36.3% of sales, for the same period in 2016.  The gross profit as a percentage of sales decreased due to a less favorable sales mix.  Low margin Export sales comprised 29.3% of total 2017 second quarter sales compared to 22.7% of total sales in the second quarter of 2016.  The 2017 second quarter gross margin percentage was also unfavorably impacted by lower AMS sales volumes and the sale of two low margin DTX printers. 

 

Selling, General and Administrative Expenses.  Selling, general and administrative expenses were $1.4 million, or 29.7% of sales, in the second quarter of 2017 compared to $1.3 million, or 31.6% of sales, for the same period in 2016.  The increase in second quarter selling, general and administrative expense in 2017 versus the same period in 2016 is related to higher trade show expenses along with increased international sales consulting expenses. 

 

Research and Development Expenses.  Research and development expenses during the second quarter of 2017 were $185,000, or 3.9% of sales, versus $147,000, or 3.5% of sales, for the same period in 2016.  The higher 2017 second quarter costs were related to an increase in production trial expenses.

 

Interest Expense.  Interest expense for the second quarter of 2017 was $21,000 compared to interest expense of $15,000 during the second quarter of 2016.  The interest expense is related to a $3.4 million financing agreement the Company entered into during 2016 to finance the construction of a 27,300-square foot building as well as related equipment for use in the Company’s manufacture of sound deadening technology used in the aerospace industry and products consisting of etched composites, ceramics, glass and silicon wafers.

 

Income Taxes. For the second quarter of 2017, the Company realized an income tax benefit of $45,000, or an effective rate of 30.0%, compared to income tax benefit of $2,000, or an effective rate of 6.1% for the same period in 2016.  The increase in the effective tax rate for 2017 over 2016 is primarily due to the impact of non-deductible items and pre-tax profit for second quarter in 2016 and its related impact on the forecasted annual rate.  In 2017, the unfavorable non-deductible items decreased the effective tax rate due to estimated pre-tax losses. The income tax provision for the 2017 and 2016 periods differ from expected tax benefit due to unfavorable non-deductible items offset by the generation of research and development tax credits.

 

Six Months Ended June 30, 2017 Compared to the Six Months Ended June 30, 2016

 

Sales.    The Company realized a 1.3% sales increase during the first six months of 2017 with sales of $8.3 million, compared to $8.2 million in sales during the same period in 2016.  Sales for the first six months of 2017 were favorably impacted by a DTX sales increase from the sale of two printers and improved consumable sales.  DTX sales for the first six months of 2017 increased from $110,000 during the same period in 2016 to $586,000, a $476,000, or 431% increase.  Export sales also realized a 10.5% sales increase for the first half of 2017 as sales grew from $2.2 million in 2016 to $2.4 million in 2017 mainly due to increased sales to Asia and Latin America.  Partially offsetting these sale increases was a $241,000, or 49.4%, decrease in AMS sales for the first half of 2017 versus the same period in 2016 due to the anticipated temporary decrease in orders from AMS’s largest customer.  It is expected that this customer will return to its normal ordering pattern in the third quarter of 2017.  Compared to the first six months of 2016, IKONICS Imaging sales decreased by $184,000 to $1.9 million in 2017.  IKONICS Imaging sales in the first six months of 2016 were favorably impacted by a large initial order from a new customer.  For the most part, a more competitive market for artwork film sales resulted in a decrease in Domestic sales from $3.3 million in the first half of 2016 to $3.1 million in 2017. 

 

Gross Profit.  Gross profit was $2.5 million, or 30.5% of sales, in the first six months of 2017 compared to $2.8 million, or 34.3% of sales, for the same period in 2016.  The gross profit as a percentage of sales decreased due to a less favorable sales mix.  Low margin Export sales comprised 29.2% of total 2017 first half sales compared to 26.8% of total sales in the first half of 2016.  The gross margin percentage for the first six months of 2017 was also unfavorably impacted by lower AMS sales volumes and the sale of two low margin DTX printers. 

 

Selling, General and Administrative Expenses.  Selling, general and administrative expenses were $2.9 million, or 34.9% of sales, in the first six months of 2017 compared to $2.8 million, or 33.7% of sales, for the same period in 2016.  The increase in selling, general and administrative expenses reflects promotional and trade show expenses for both Export and IKONICS Imaging in addition to higher international sales consulting expenses.

 

12


 

Research and Development Expenses.  Research and development expenses during the first six months of 2017 were $350,000, or 4.2% of sales, versus $325,000, or 4.0% of sales, for the same period in 2016. The higher 2017 first half costs were related to an increase in production trial and supply expenses.

 

Interest Expense.  Interest expense for the first six months of 2017 was $42,000 compared to interest expense of $15,000 during the first six months of 2016.  The interest expense is related to a $3.4 million financing agreement the Company entered into during 2016 to finance the construction of a 27,300-square foot building as well as related equipment for use in the Company’s manufacture of sound deadening technology used in the aerospace industry and products consisting of etched composites, ceramics, glass and silicon wafers.

 

Income Taxes.  For the first six months of 2017, the Company realized an income tax benefit of $268,000, or an effective rate of 35.6%, compared to income tax benefit of $130,000, or an effective rate of 45.8%, for the same period in 2016.  The decrease in the effective tax rate for 2017 over 2016 is primarily due to higher pre-tax loss for the current year and the impact of non-deductible items.   The income tax provision for the 2017 and 2016 periods differ from expected tax benefit due to unfavorable non-deductible items, offset by the generation of research and development tax credits.

 

Liquidity and Capital Resources

 

Outside of the building expansion, for which $3.4 million in financing was obtained during 2016, the Company has financed its operations principally with funds generated from operations.  These funds have been sufficient to cover the Company’s normal operating expenditures, annual capital requirements, and research and development expenditures.

 

Cash and cash equivalents were $1.2 million and $1.0 million at June 30, 2017 and December 31, 2016, respectively.  Operating activities provided $51,000 in cash during the first six months of 2017 compared to $528,000 of cash provided by operating activities during the same period in 2016.  Cash provided by operating activities is primarily the result of a net loss adjusted for non-cash depreciation, amortization, gain on sale and disposal of property, and certain changes in working capital components discussed in the following paragraph.

 

During the first six months of 2017, the timing of collections resulted in a $270,000 decrease in trade receivables.  The Company believes that the quality of its receivables is high and that strong internal controls are in place to maintain proper collections.  Inventories increased by $290,000 due to higher raw material and finished goods levels.  Prepaid expenses and other assets decreased $215,000.  The prepaid expense balance at December 31, 2016 included prepayments related to two DTX printers which have since been sold.  Accounts payable increased $144,000 due to the timing of vendor payments mainly related to raw material purchases.  Accrued expenses decreased $27,000, reflecting the timing of compensation payments while income taxes receivable increased $208,000 due to the timing of estimated tax payments compared to the calculated 2017 tax liability.

 

During the first six months of 2016, the decrease in sales along with the timing of collections resulted in a $354,000 decrease in trade receivables.  Inventories increased by $96,000 due to higher raw material levels.  Prepaid expenses and other assets increased $56,000, reflecting insurance premiums paid in advance.  Accounts payable increased $90,000 due to the timing of vendor payments.  Accrued expenses increased $45,000, reflecting the timing of compensation payments while income taxes receivable increased $29,000 due to the timing of estimated tax payments compared to the calculated 2016 tax liability.

 

During the first six months of 2017, cash provided by investing activities was $224,000.  The Company obtained proceeds from ten certificates of deposits totaling $2.3 million and purchased eight certificates of deposits totaling $1.9 million.  The Company’s purchases of property and equipment of $134,000 were mainly for improvements to production and process capabilities and a vehicle. Also, during the first six months of 2017, the Company incurred $15,000 in patent application costs that the Company has recorded, as an asset and will amortize upon successful completion of the application process.  In addition the Company sold a vehicle for $22,000. 

 

During the first six months of 2016, cash used in investing activities was $5.2 million.  The Company purchased fifteen certificates of deposits totaling $3.4 million.  The Company’s cash purchases of property and equipment were $1.8 million.  Total building expansion expenditures were $1.4 million but $23,000 of the

13


 

expenditures were included as part of construction payable and not as cash used in investing activities.  Similarly, expenditures on the new ERP system in the first six months of 2016 were $171,000 of which $37,000 was included as part of construction payable and not as cash used in investing activities.  The remaining capital expenditures were mainly for upgrades to improve AMS production and process capabilities. Also during the first six months of 2016, the Company incurred $22,000 in patent application costs that the Company records as an asset and amortizes upon successful completion of the application process.  In addition, the Company sold equipment for $21,000. 

 

Related to the Company’s loan, the Company made principal payments of $70,000 during the first six months of 2017.  During the first six months of 2017, the Company received $2,000 from financing activities from the issuance of 250 shares of common stock due to the exercise of stock options while the Company repurchased 270 shares of its own stock during the first half of 2017 for $15,000. 

 

During the first six months of 2016 the Company received $3.3 million from financing activities.   The Company secured a loan of $3.4 million to finance the expansion of its AMS facility.  Related to the securing of the loan, the Company paid $139,000 in debt issuance costs and made a principal payment of $11,000.   During the first six months of 2016, the Company received $4,000 from the issuance of 500 shares of common stock from the exercise of stock options. 

 

A bank line of credit exists providing for borrowings of up to $2,050,000 and expires on June 30, 2019.  The line of credit is collateralized by the Company’s assets and bears interest at 1.8 percentage points over the 30‑day LIBOR rate.  The Company did not utilize this line of credit during the first six months of 2017 or 2016 and there were no borrowings outstanding as of June 30, 2017 and December 31, 2016.  There are no financial covenants related to the line of credit. 

 

The Company believes that current financial resources, its line of credit, cash generated from operations and secured through debt financing, and short term investments, along with the Company’s capacity for additional debt and/or equity financing will be sufficient to fund current and anticipated business operations.  The Company also believes that it is unlikely that a decrease in demand for the Company’s products would impair the Company’s ability to fund operations given its excess cash and available line of credit.

 

Capital Expenditures

 

Through the first six months of 2017, the Company incurred $134,000 of capital expenditures mainly for improvements to production and process capabilities and a vehicle.

 

The Company expects additional capital expenditures in 2017 of approximately $450,000 mainly for AMS process improvements, enhancements to emulsion and film production and replacement automobiles for sales personnel.  Currently, the Company expects to fund its capital expenditures with existing cash and cash generated from operating activities. 

 

International Activity

 

The Company markets its products to numerous countries in North America, Europe, Latin America, Asia and other parts of the world.  Foreign sales were approximately 33.6% of total sales during the first six months of 2017 compared to 29.3% of total sales for the same period in 2016.  Foreign sales increased in 2017 due to the sale of two DTX printers into Europe along improved consumable sales to Asia and Latin America.  Fluctuations of certain foreign currencies have not significantly impacted the Company’s operations, as the Company’s foreign sales are not concentrated in any one region of the world, although a strong U.S. dollar does make the Company’s products less competitive internationally.  The Company believes its vulnerability to uncertainties due to foreign currency fluctuations and general economic conditions in foreign countries is not significant.

 

The Company’s foreign transactions are primarily negotiated, invoiced and paid in U.S. dollars, although a portion is transacted in Euros.  IKONICS has not implemented an economic hedging strategy to reduce the risk of foreign currency translation exposures, as management does not believe this to be a significant risk based on the scope and geographic diversity of the Company’s foreign operations as of June 30, 2017.  Furthermore, the impact of foreign exchange on the Company’s balance sheet and operating results was not material in either 2017 or 2016.

14


 

 

Future Outlook

 

IKONICS has spent an average of approximately 4.0% of annual sales in research and development and has made capital expenditures related to new products and programs.  The Company plans to maintain its efforts in these areas to expedite internal product development as well as to form technological alliances with outside entities to commercialize new product opportunities.

 

The Company continues to make progress on its AMS business initiative.  Although AMS experienced a short-term drop in sales during the first six months of 2017 due to a temporary inventory overstocking by a major customer, these sales have returned and the Company anticipates continued growth over the long term.  The Company has two long-term sales agreements in place for its technology with major aerospace companies and is negotiating a third.  In anticipation of this growing business, the Company increased its AMS capacity with a 27,300 square foot expansion at its Morgan Park site in 2016.

 

The Company is also continuing to pursue DTX-related business initiatives and expects increased consumable sales as a result of the sale of two DTX printers in the second quarter of 2017.  In addition to making efforts towards growing the inkjet technology business, the Company offers a range of products for creating texture surfaces and has introduced a fluid for use in prototyping.  The Company is currently working on production improvements to enhance its customer offerings.  The Company has been awarded European, Japanese, and United States patents on its DTX technologies.  The Company has also modified its DTX technology to enter into the market for prototyping. 

 

Both the Domestic and IKONICS Imaging units remain profitable in mature markets. Although these business units require aggressive strategies to grow market share, both are developing new products and business relationships that we believe will contribute to growth.  In addition to its traditional emphasis on domestic markets, the Company will continue efforts to grow its business internationally by attempting to develop new markets and expanding market share where it has already established a presence. However, the strong U.S. dollar has made this challenging.

 

Other future activities undertaken to expand the Company’s business may include acquisitions, building improvements, equipment additions, new product development and marketing opportunities.

 

 

Recent Accounting Pronouncements

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-09, Revenue from Contracts with Customers.  ASU 2014-09 supersedes the revenue recognition requirements in Revenue Recognition (Topic 605), and requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services.  In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, which defers the adoption of ASU 2014-09 to annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period.   The standard permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (the cumulative catch-up transition method).  The standard also requires expanded disclosures relating to the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. Additionally, qualitative and quantitative disclosures are required about customer contracts, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract.  While the Company is still in the process of evaluating the effect of adoption on its financial statements and is currently assessing its contracts with customers, the Company anticipates that it will expand its financial statement disclosures in order to comply with the new standard.  The Company has established a timeline and process to evaluate the impact, transition and disclosure requirements of the ASU and believes the timeline is sufficient to allow the Company to effectively implement the

15


 

new standard.  The Company has not yet concluded on a transition method upon adoption, but plans to select a transition method by the fourth quarter of 2017.

 

During February 2016, the FASB issued ASU No. 2016-02, Leases. ASU No. 2016-02 was issued to increase transparency and comparability among organizations by recognizing all lease transactions (with terms in excess of 12 months) on the balance sheet as a lease liability and a right-of-use asset (as defined). ASU No. 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, with earlier application permitted.  Upon adoption, the lessee will apply the new standard retrospectively to all periods presented or retrospectively using a cumulative effect adjustment in the year of adoption. The Company is currently assessing the effect that ASU No. 2016-02 will have on its financial statements.

 

In March 2016, the FASB issued ASU No. 2016-09, Compensation—Stock Compensation (Topic 718). This standard makes several modifications to Topic 718 related to the accounting for forfeitures, employer tax withholding on share-based compensation and the financial statement presentation of excess tax benefits or deficiencies. ASU 2016-09 also clarifies the statement of cash flows presentation for certain components of share-based awards. The standard is effective for interim and annual reporting periods beginning after December 15, 2016, although early adoption is permitted. The Company adopted ASU No. 2016-09 in 2017 with minimal impact on the financial statements.

 

 

Off-Balance Sheet Arrangements

 

The Company has no off-balance sheet arrangements.

 

 

ITEM 3.  Quantitative and Qualitative Disclosures about Market Risk

 

Not applicable

 

ITEM 4.  Controls and Procedures

 

As of the end of the period covered by this report, the Company conducted an evaluation, under the supervision and with the participation of the principal executive officer and principal financial officer, of the Company’s disclosure control and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)).  Based on this evaluation, the principal executive officer and principal financial officer concluded that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and (ii) accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

There was no change in the Company’s internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and Rule 15d-15(d) of the Exchange Act that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

16


 

PART II.OTHER INFORMATION

 

ITEM 1.              Legal Proceedings

 

None

 

ITEM 1A.           Risk Factors

 

Not applicable

 

ITEM 2.              Unregistered Sales of Equity Securities and Use of Proceeds

The Company repurchased shares as indicated in the table below during the second quarter of 2017(1)

 

 

 

 

 

 

 

 

 

 

 

 

    

(a) Total
Number
of Shares
Purchased

   

(b) Average
Price
Paid per
Share